Uterine myoma is the most common benign tumor in women of reproductive age [1]. Leiomyoma affects 25% to 50% of women of reproductive age, and at least 50% of patients have significant symptoms [2]. Common symptoms of myoma include menorrhagia, metrorrhagia, dysmenorrhea, and pressure symptoms. The process of myoma development is not well understood and can continue until menopause. Indications for surgery include abnormal uterine bleeding, unresponsiveness to medical therapy, pain or pressure symptoms, urinary signs or symptoms, a high level of malignancy, growth after menopause, infertility with endometrial distortion, and recurrent pregnancy loss [1]. For preservation of fertility, myomectomy is carried out in women of reproductive age with symptomatic uterine myoma. With the development of laparoscopic equipment and establishment of laparoscopic surgical settings, the indications for gynecologic laparoscopy have been extended. Nowadays, laparoscopic operation is generally preferred because of its good cosmetic results, reduced pain levels, short hospitalization time, quick recovery time, and similar outcomes as those of laparotomy [3]. LAPAROSCOPIC CERVICAL MYOMECTOMY: FIVE YEARS OF EXPERIENCE ObjectiveThis retrospective case series evaluated the feasibility and safety of laparoscopic cervical myomectomy. MethodsSixty-five patients with cervical myoma who underwent laparoscopic cervical myomectomy were included in this study. ResultsThe mean age of the patients was 39.2 ± 6.0 years. The marriage rate was 67.7%, and the mean parity was 1.09. The most common symptoms in the patients were increased myoma size (41.5%) and menorrhagia (13.8%), while 20% of patients were asymptomatic. The average diameter of the myomas treated was 72.68 ± 20.28 mm, and the mean number of myomas per patient was 1.41± 0.88. Laparoscopic cervical myomectomy required a mean time of 63.25 ± 20.34 minutes. The difference between preoperative and postoperative hemoglobin levels was 2.01± 0.73 g/dL, and no patient required transfusion or conversion to laparotomy. ConclusionSixty-five procedures of laparoscopic cervical myomectomy were performed safely. Operation time and complications were minimal. With correct understanding of pelvic anatomy, laparoscopic cervical myomectomy can be carried out safely and easily, and represents a minimally invasive treatment choice for symptomatic cervical myoma.
ObjectiveTo assess changes in endometrial polyps by sonohysterography. MethodsWe conducted a retrospective analysis of 57 premenopausal women who were suspected to have endometrial polyps and were examined by sonohysterography from October 2005 to July 2008. We evaluated changes in endometrial polyps by sonohysterography after observation for two or more menstrual cycles. ResultsThe mean age of the patients was 37.7, and all patients were premenopausal. Forty-two patients had bleeding symptoms, the most common being intermenstrual spotting. Endometrial polyps regressed spontaneously in 15 out of 57 patients (26.3%). The endometrial polyp regression rate was not associated with symptoms, age, body mass index, gravida, parity, initial largest polyp diameter or interval between sonohysterography. Of the 42 patients with persistent polyps, 29 received surgical treatment. None of the patients had malignant lesions. ConclusionEndometrial polyps in premenopausal patients with low malignant potential may be observed for about two menstrual cycles in the hope of spontaneous regression.
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.